EBIT: Income before interest and taxes.
PMV Pharmaceuticals, Inc. (PMVP) had EBIT of $-80.13M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-68.96M |
|
-- |
|
-- |
|
$80.13M |
|
$-80.13M |
|
$11.17M |
|
$-68.96M |
|
$-68.96M |
|
$-68.96M |
|
$-68.96M |
|
$-68.96M |
|
$-68.96M |
|
|
EBIT |
$-80.13M |
$-84.26M |
|
48.02M |
|
48.02M |
|
$-1.44 |
|
$-1.44 |
|
| Balance Sheet Financials | |
$207.41M |
|
$10.67M |
|
$44.74M |
|
$252.15M |
|
$14.03M |
|
-- |
|
$12.43M |
|
$26.46M |
|
$225.69M |
|
$225.69M |
|
$225.69M |
|
51.45M |
|
| Cash Flow Statement Financials | |
$-55.66M |
|
$-50.55M |
|
$35.58M |
|
$109.12M |
|
$38.53M |
|
$-70.59M |
|
$12.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-56.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.56% |
|
-30.56% |
|
-27.35% |
|
-30.56% |
|
$4.39 |
|
$-1.18 |
|
$-1.16 |
|